News and Updates

The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for the T1D community.

The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for the T1D community.

From June 23-26, Breakthrough T1D researchers will present new study results at the American Diabetes Association's 83rd Scientific Sessions.

Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.

Gastroparesis is a condition when the stomach is unable to empty itself properly, leading to problems such as becoming full too early, nausea, and vomiting.

Breakthrough T1D staff share their experiences with diabetic eye disease to help raise awareness of the importance of being proactive when it comes to vision health.

Aspect and Novo Nordisk announce a partnership, using Aspect’s bioprinting technology and Novo Nordisk’s expertise, to develop treatments for diabetes.

JDRF’s Chief Mission Strategy Officer will leave behind quite a legacy once she steps down from her role at Breakthrough T1D at the end of March 2023.

Meet two type 1 diabetes (T1D) clinical trial participants who are helping improve lives and getting us closer to cures, one study at a time.

Beta cell replacement therapies aim to overcome the obstacles to realize their potential, but several approaches are making them a thing of the past.